Tags: Drug.

Mifamurtide (trade name Mepact marketed by Takeda) is a drug against osteosarcoma a kind of bone cancer mainly affecting children and young adults which is lethal in about a third of cases. The drug was approved in Europe in March 2009.

Mifamurtide.svg
ATC prefix
L03
ATC suffix
AX15
CAS number
83461-56-7
CAS supplemental
(mifamurtide sodium · xH2O)
FDA UNII code
EQD2NNX741
IUPAC name
2-[(N-(2R)-[(2-acetamido-23-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl-(L)-alanyl-(D)-isoglutaminyl-(L)-alanyl)amino]ethyl (2R)-23-bis(hexadecanoyloxy)propyl hydrogen phosphate
PubChem
23725093

Loading...

This page contains content from the copyrighted Wikipedia article "Mifamurtide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.